0001181431-12-026424.txt : 20120430 0001181431-12-026424.hdr.sgml : 20120430 20120430180202 ACCESSION NUMBER: 0001181431-12-026424 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120426 FILED AS OF DATE: 20120430 DATE AS OF CHANGE: 20120430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WALLACE JOHN J CENTRAL INDEX KEY: 0001194458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34031 FILM NUMBER: 12797061 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOLL MEDICAL CORP CENTRAL INDEX KEY: 0000887568 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 042711626 STATE OF INCORPORATION: MA FISCAL YEAR END: 1001 BUSINESS ADDRESS: STREET 1: 269 MILL ROAD CITY: CHELMSFORD STATE: MA ZIP: 01824-4105 BUSINESS PHONE: 9784219655 MAIL ADDRESS: STREET 1: 269 MILL ROAD CITY: CHELMSFORD STATE: MA ZIP: 01824-4105 FORMER COMPANY: FORMER CONFORMED NAME: ZOLL MEDICAL CORPORATION DATE OF NAME CHANGE: 19930328 4 1 rrd343422.xml J WALLACE 4-26-2012 X0305 4 2012-04-26 1 0000887568 ZOLL MEDICAL CORP ZOLL 0001194458 WALLACE JOHN J 270 CLARENDON STREET, #2 BOSTON MA 02116 1 0 0 0 Common Stock 2012-04-26 4 D 0 2000 93 D 0 D Common Stock 2012-04-26 4 M 0 20000 25.51 A 20000 D Common Stock 2012-04-26 4 M 0 2000 23.05 A 22000 D Common Stock 2012-04-26 4 M 0 2000 22.05 A 24000 D Common Stock 2012-04-26 4 M 0 2000 20.23 A 26000 D Common Stock 2012-04-26 4 M 0 4000 42.86 A 30000 D Common Stock 2012-04-26 4 D 0 30000 93 D 0 D Stock Option 25.51 2012-04-26 4 M 0 20000 0 D 2008-04-27 2017-04-27 Common Stock 20000 0 D Stock Option 23.05 2012-04-26 4 M 0 2000 0 D 2008-11-14 2017-11-14 Common Stock 2000 0 D Stock Option 22.05 2012-04-26 4 M 0 2000 0 D 2009-11-11 2018-11-11 Common Stock 2000 0 D Stock Option 20.23 2012-04-26 4 M 0 2000 0 D 2010-11-10 2019-11-10 Common Stock 2000 0 D Stock Option 42.86 2012-04-26 4 M 0 4000 0 D 2012-01-26 2021-01-26 Common Stock 4000 0 D These restricted stock awards vested in full and were cancelled immediately prior to the effective time of the merger (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated March 12, 2012, by and among ZOLL Medical Corporation, Asahi Kasei Corporation, Asahi Kasei Holdings US, Inc. and Asclepius Subsidiary Corporation (the "Merger Agreement") in exchange for an aggregate cash payment equal to the number of shares of ZOLL Medical Corporation's common stock underlying such restricted stock awards multiplied by the per share purchase price of $93.00. Disposed of at the effective time of the Merger pursuant to the terms of the Merger Agreement. Represents options under ZOLL Medical Corporation's Amended and Restated 2001 Stock Incentive Plan that were either fully exercisable or accelerated in full and exercised pursuant to the terms of the Merger Agreement. /s/ Maureen Callahan, By Power of Attorney 2012-04-30